McKesson Corporation announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
528.9 USD | -0.27% | -2.66% | +14.23% |
30/04 | Citigroup Adjusts Price Target on McKesson to $620 From $575 | MT |
24/04 | McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.23% | 69.5B | |
+7.11% | 8.2B | |
-20.55% | 7.97B | |
-4.06% | 7.84B | |
+2.26% | 4.66B | |
+17.12% | 4.32B | |
+1.41% | 4.19B | |
-3.02% | 3.89B | |
+21.42% | 3.62B | |
+8.64% | 3.41B |
- Stock Market
- Equities
- MCK Stock
- News McKesson Corporation
- McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health